Chlamydia trachomatis: Impact on Chromatin and Gene Expression
Chlamydia trachomatis alters chromatin structure, affecting gene expression and immune responses.
― 6 min read
Table of Contents
- Chromatin Structure and Modifications
- The Role of Metabolism in Chromatin Dynamics
- Bacterial Infection and Histone Methylation Changes
- The Effects of Histone Methylation on Gene Expression
- Metabolic Imbalance and Demethylase Activity
- Experimental Evidence of Histone Changes
- Impact of Bacterial Activity on Histone Changes
- Repairing Demethylase Activity
- Effects on Host Gene Expression
- Suppression of Anti-Inflammatory Responses
- Conclusion
- Original Source
- Reference Links
Chlamydia Trachomatis is a bacterium that causes sexually transmitted infections and can also infect the eyes. It affects cells in various parts of the body, particularly those lining the genitals and the eyes. When this bacterium infects a cell, it not only multiplies but also has an effect on the cell's genetic material and how it functions. One of the key areas affected is the Chromatin, which is a complex of DNA and proteins found in the nucleus of most cells. These changes can impact gene expression, which is how cells use information from their genes to produce proteins that perform specific functions.
Chromatin Structure and Modifications
Chromatin can exist in a compact or relaxed state, which influences whether genes can be accessed and activated. The structure of chromatin is influenced by chemical modifications of DNA and histones, which are the proteins that help package DNA. Two well-known modifications are DNA methylation and histone methylation.
- DNA Methylation: This process usually silences genes, making them less accessible for expression.
- Histone Methylation: This can either activate or silence genes, depending on which histone is modified and where.
The overall behavior of chromatin directly affects how cells react to various stimuli, including infections.
The Role of Metabolism in Chromatin Dynamics
Recent findings indicate that the metabolism of a cell can influence chromatin structure. Some Metabolites-substances produced during metabolism-are necessary for the processes that modify chromatin. For example, S-adenosyl methionine (SAM) is required for certain methylation reactions, while substances like 2-oxoglutarate (aK-G) and iron also play crucial roles. Changes in the availability of these metabolites can thus affect how chromatin is modified.
When Chlamydia trachomatis infects cells, it alters the metabolite landscape, which can impact the activity of proteins that modify chromatin. This can lead to significant changes in how genes are expressed within the infected cells.
Bacterial Infection and Histone Methylation Changes
Studies have demonstrated that when cells are infected with Chlamydia trachomatis, there is an increase in certain histone methylation marks. This increase is not uniform across all cells but varies depending on the level of infection. Infected cells may show different levels of methylation, and as the infection progresses, more cells exhibit high levels of these modifications.
Strikingly, within individual cells, different histone modifications often correlate. This means that when one histone mark is present at high levels, others are likely to be as well. This pattern suggests a broad change in how chromatin is structured during infection.
The Effects of Histone Methylation on Gene Expression
Histone methylation during Chlamydia infection was found to influence the expression of genes related to the immune response. Some genes that are typically activated during an infection may not respond properly due to the altered chromatin state.
For instance, in infected cells, histones marked for activation (like H3K4me3) and for repression (like H3K9me3) can both exhibit increased methylation. This makes it difficult to predict the overall effect on gene expression, as opposing signals can lead to conflicting outcomes.
Metabolic Imbalance and Demethylase Activity
The high levels of histone methylation observed in infected cells suggest a failure of demethylation, the process that removes methyl groups from histones and allows for gene activation. This failure could stem from a lack of essential metabolites needed for the proper functioning of demethylases, the enzymes that carry out demethylation.
During the later stages of infection, the concentrations of metabolites like SAM and aK-G drop significantly, likely due to the bacterial consumption of these compounds. This drop impairs the activity of demethylases and results in the accumulation of methylated histones.
Experimental Evidence of Histone Changes
Research involving various cultured cell types, including primary cells from infected individuals, has shown consistent patterns of histone methylation during Chlamydia infection. When these cells were analyzed, a clear increase in methylation levels was noted, particularly for specific marks associated with both gene activation and repression.
Further experiments involving proteomic analysis revealed a global increase in the methylation of proteins, beyond just histones. This suggests that the infection triggers a metabolic response that impacts many cellular proteins, not just those involved in chromatin dynamics.
Impact of Bacterial Activity on Histone Changes
The presence of live bacteria was shown to correlate with increased histone methylation. When the growth of Chlamydia was inhibited through antibiotics, the levels of histone methylation decreased, confirming the link between bacterial activity and changes in chromatin structure.
Interestingly, a specific bacterial protein known as Nue was suspected to contribute to histone methylation. However, even in the absence of Nue, histone hypermethylation still occurred, indicating that other factors related to the infection and metabolic changes were at play.
Repairing Demethylase Activity
Considering that the infection state reduces demethylase activity, researchers sought to explore options to restore this activity. They tested the effects of providing additional iron and aK-G to infected cells. These compounds are known to support the function of demethylases.
Supplementation with these compounds showed a partial reversal of histone hypermethylation, suggesting that access to these critical metabolites could help restore normal demethylase function during infection.
Effects on Host Gene Expression
The changes in histone modification were linked to the transcriptional response of the host cells during infection. When the environment was altered through the addition of aK-G, significant differences in gene expression patterns emerged. Many genes that were upregulated during infection were downregulated with aK-G treatment, indicating that chromatin changes had a direct impact on how the immune system responded.
Particularly, the expression levels of several important inflammatory markers, such as CCL20 and IL-6, were modulated by the metabolic state of the cells. This highlights the potential for metabolic interventions to affect how cells respond to infections.
Suppression of Anti-Inflammatory Responses
As the infection progresses, an anti-inflammatory response often develops, leading to a decrease in immune signaling. This phenomenon was observed in mice infected with Chlamydia, where the levels of various cytokines diminished over time.
The data suggested that adequate demethylase activity was necessary for proper resolution of inflammation. When demethylase activity was inhibited through the use of specific inhibitors, the acute inflammatory response was dampened, indicating a potential role for these enzymes in managing the immune response during infection.
Conclusion
Chlamydia trachomatis infection leads to significant changes in chromatin structure and dynamics, primarily through alterations in histone methylation patterns. These changes arise from a complex interplay of bacterial metabolism and host cellular responses.
The overall findings suggest that metabolic changes during infection can have far-reaching consequences on chromatin modifications, potentially impacting gene expression and the host's immune response. By targeting metabolites involved in histone modifications, it may be possible to influence how cells respond to Chlamydia infection, paving the way for new therapeutic strategies.
Research continues to unravel the intricate relationships between bacterial infection, metabolism, and chromatin dynamics, offering insights that could be crucial for developing effective interventions against Chlamydia and similar pathogens.
Title: Metabolic imprint of an intracellular pathogen drives histone hypermethylation and tunes the host transcriptional response to infection
Abstract: Chlamydia trachomatis, an intracellular bacterium, highjacks metabolites from the host cell. We provide evidence of global hypermethylation of the host proteome, including histones, during the late stages of infection and that histone hypermethylation is the result of metabolic imbalance favoring the activity of lysine methyl transferases over demethylases. We find that histones hypermethylated at residues H3K4 and H3K9 are distributed throughout the chromatin. Inhibition of bacterial growth, or supplementation of the culture medium with iron or with dimethyl-ketoglutarate (DMKG) reduced histone hypermethylation. DMKG supplementation modified the transcription of about one third of the infection-responsive genes, including genes involved in the innate response to infection. Transfer RNA (tRNA) levels decreased late in infection and DMKG supplementation prevented this phenomenon. Finally, we uncovered a robust, histone demethylase dependent shut-down of the innate response in the mouse genital tract shortly after the acute phase of infection. Overall, our data show that the metabolic pressure exerted by a pathogen with an intracellular lifestyle drives an epigenetic imprint that tunes the transcriptional response of its host.
Authors: Agathe Subtil, C. I. Charendoff, F. V. Louchez, Y. Wu, L. Dolat, G. Velasco, S. Perrinet, A. G. Torres, L. Blanchet, M. Duchateau, Q. G. Gianetto, M. Matondo, L. Del Maestro, S. Ait-Si-Ali, F. Bonhomme, G. Millot, L. Ribas de Pouplana, E. D. Martinez, R. Valdivia
Last Update: 2024-06-05 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.06.04.597420
Source PDF: https://www.biorxiv.org/content/10.1101/2024.06.04.597420.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.